Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results

Go back to Axogen, Inc. Reports Fourth Quarter and Full-Year 2019 Financial Results

AxoGen (AXGN) Misses Q4 EPS by 1c

February 24, 2020 4:13 PM EST

AxoGen (NASDAQ: AXGN) reported Q4 EPS of ($0.10), $0.01 worse than the analyst estimate of ($0.09). Revenue for the quarter came in at $28.1 million versus the consensus estimate of $29.23 million.

I am pleased with our fourth quarter and full-year performance. We delivered solid revenue growth and... More